Reduced signal on fluorodeoxyglucose-positron emission tomography (FDG-PET) is a valid proxy for neurodegeneration in Alzheimer’s disease (AD). Perivascular space (PVS) is believed to be associated with AD pathology and cognitive decline.
Objective:
This study aimed to investigate the associations of PVS with FDG-PET and cognitive performance based on the burden of amyloid pathology.
Methods:
We used magnetic resonance imaging (MRI) data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). MRI-visible PVS in basal ganglia (BG) and centrum semi-oval (CSO) were visually classified as: none/mild, moderate or frequent/severe. The association of PVS with brain FDG-PET was explored based on the burden of amyloid pathology, where a cerebrospinal fluid (CSF) t-tau/Aβ42 with the ratio≥0.27 was defined as high amyloid pathology. Moreover, the relationships between PVS and cognitive performance variables (ADNI-MEM and ADNI-EF) were studied.
Results:
For participants with higher tau/Aβ42 ratio, CSO-PVS severity was independently associated with lower FDG-PET. There were significant interaction effects between moderate or frequent/severe CSO-PVS and time on FDG decline in people with high amyloid pathology. The interaction between CSO-PVS and time (follow-up) was consistently associated with ADNI-MEM and ADNI-EF decline in individuals with high amyloid pathology.
Conclusion:
The study established the differential utility of PVS in BG and CSO for predicting brain metabolism. These findings suggest that CSO-PVS serves as a contributing factor to brain metabolism and cognitive decline associated with amyloid pathology.
LiH, LiuCC, ZhengH, HuangTY (2018) Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease -conformist, nonconformist, and realistic prospects for AD pathogenesis. Transl Neurodegener7, 34.
3.
GiacobboBL, MediavillaT, MarcellinoDJ, SultanF (2021) Metabolic changes in an animal model of amyotrophic lateral sclerosis evaluated by [(18)F]-FDG positron emission tomography. Transl Neurodegener10, 21.
BrownR, BenvenisteH, BlackSE, CharpakS, DichgansM, JoutelA, NedergaardM, SmithKJ, ZlokovicBV, WardlawJM (2018) Understanding the role of the perivascular space in cerebral small vessel disease. Cardiovasc Res114, 1462–1473.
6.
YamadaS, IshikawaM, YamamotoK, YamaguchiM, OshimaM (2019) Location-specific characteristics of perivascular spaces as the brain’s interstitial fluid drainage system. J Neurol Sci398, 9–15.
7.
ParkYW, ShinNY, ChungSJ, KimJ, LimSM, LeePH, LeeSK, AhnKJ (2019) Magnetic resonance imaging-visible perivascular spaces in basal ganglia predict cognitive decline in Parkinson’s disease. Mov Disord34, 1672–1679.
8.
BanerjeeG, KimHJ, FoxZ, JägerHR, WilsonD, CharidimouA, NaHK, NaDL, SeoSW, WerringDJ (2017) MRI-visible perivascular space location is associated with Alzheimer’s disease independently of amyloid burden. Brain140, 1107–1116.
9.
KimHJ, ChoH, ParkM, KimJW, AhnSJ, LyooCH, SuhSH, RyuYH (2021) MRI-visible perivascular spaces in the centrum semiovale are associated with brain amyloid deposition in patients with Alzheimer disease-related cognitive impairment. AJNR Am J Neuroradiol42, 1231–1238.
WardlawJM, SmithEE, BiesselsGJ, CordonnierC, FazekasF, FrayneR, LindleyRI, O’BrienJT, BarkhofF, BenaventeOR, BlackSE, BrayneC, BretelerM, ChabriatH, DecarliC, de LeeuwFE, DoubalF, DueringM, FoxNC, GreenbergS, HachinskiV, KilimannI, MokV, OostenbruggeR, PantoniL, SpeckO, StephanBC, TeipelS, ViswanathanA, WerringD, ChenC, SmithC, van BuchemM, NorrvingB, GorelickPB, DichgansM (2013) Neuroimaging standards forresearch into small vessel disease and its contribution to ageingand neurodegeneration. Lancet Neurol12, 822–838.
15.
CranePK, CarleA, GibbonsLE, InselP, MackinRS, GrossA, JonesRN, MukherjeeS, CurtisSM, HarveyD, WeinerM, MungasD (2012) Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav6, 502–516.
16.
Martinez-RamirezS, van RoodenS, CharidimouA, van OpstalAM, WermerM, GurolME, TerwindtG, van der GrondJ, GreenbergSM, van BuchemM, ViswanathanA (2018) Perivascular spaces volume in sporadic and hereditary (Dutch-Type) cerebral amyloid angiopathy. Stroke49, 1913–1919.
17.
RoherAE, KuoYM, EshC, KnebelC, WeissN, KalbackW, LuehrsDC, ChildressJL, BeachTG, WellerRO, KokjohnTA (2003) Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer’s disease. Mol Med9, 112–122.
18.
WangML, YuMM, WeiXE, LiWB, LiYH (2021) Association of enlarged perivascular spaces with Aβ and tau deposition in cognitively normal older population. Neurobiol Aging100, 32–38.
19.
BouvyWH, BiesselsGJ, KuijfHJ, KappelleLJ, LuijtenPR, ZwanenburgJJ (2014) Visualization of perivascular spaces and perforating arteries with 7 T magnetic resonance imaging. Invest Radiol49, 307–313.
20.
IshikawaM, YamadaS, YamamotoK (2015) Three-dimensional observation of Virchow-Robin spaces in the basal ganglia and white matter and their relevance to idiopathic normal pressure hydrocephalus. Fluids Barriers CNS12, 15.
21.
HuijtsM, DuitsA, StaalsJ, KroonAA, de LeeuwPW, van OostenbruggeRJ (2014) Basal ganglia enlarged perivascular spaces are linked to cognitive function in patients with cerebral small vessel disease. Curr Neurovasc Res11, 136–141.
22.
HilalS, TanCS, AdamsHHH, HabesM, MokV, VenketasubramanianN, HoferE, IkramMK, AbrigoJ, VernooijMW, ChenC, HostenN, VolzkeH, GrabeHJ, SchmidtR, IkramMA (2018) Enlarged perivascular spaces and cognition: A meta-analysis of 5 population-based studies, Neurology91, e832–e842.
23.
BalleriniL, LovreglioR, Valdés HernándezMDC, RamirezJ, MacIntoshBJ, BlackSE, WardlawJM (2018) Perivascular spacessegmentation in brain MRI using optimal 3D filtering. Sci Rep8, 2132.
24.
SepehrbandF, BarisanoG, Sheikh-BahaeiN, ChoupanJ, CabeenRP, LynchKM, CrawfordMS, LanH, MackWJ, ChuiHC, RingmanJM, TogaAW (2021) Volumetric distribution of perivascular space in relation to mild cognitive impairment. Neurobiol Aging99, 28–43.
25.
PotterGM, ChappellFM, MorrisZ, WardlawJM (2015) Cerebral perivascular spaces visible on magnetic resonance imaging: Development of a qualitative rating scale and its observer reliability. Cerebrovasc Dis39, 224–231.
